New Hampshire's Therapeutic Cannabis Program has seen an increase of 14.5% in new patients, bringing the total registry to nearly 17,000, due to changes in state law…
Hemab Therapeutics and Seaport Therapeutics are the newest biotech companies to join the public markets, each with an upsized IPO. According to IPO research firm…
Lifestyle modifications, particularly increased physical activity, have a host of benefits. New research suggests they may ease or even reverse symptoms of Parkinson's…
New research challenges widely held assumptions about medicinal cannabis, particularly in mental health care. A sweeping new analysis published in The Lancet Psychiatry…
With about 1 in 6 Americans 12 and older saying they've used cannabis in the past month, more research is needed on its effects. But U.S. law makes real data hard to…
Thriveworks reports on managing travel anxiety, emphasizing the importance of recognizing fears, controlling what you can, and preparing coping strategies.
Tonix Pharmaceuticals announced the publication of pharmacokinetic research on TONMYA (cyclobenzaprine HCl sublingual tablets), the first new FDA-approved treatment for…
While anxiety itself is a normal, adaptive emotion that helps people respond to perceived threats, it becomes an anxiety disorder when fears or worry are persistent,…
Enanta Pharmaceuticals has announced the first participant enrollment in a Phase 1 clinical trial of EDP-978, an oral, once-daily KIT inhibitor being developed to treat…
(NaturalHealth365) Anxiety disorders affect approximately 30% of American adults, making them the most common mental illness in the country. For decades, treatment has…
This proposal outlines a unified primary care payment model across Medi-Cal, CalPERS, and Covered California. The post Medi-Cal Bold Idea — Multipayer Primary Care…
Dentistry.com reports that rising dental emergencies are increasing demand for after-hours dentist services, alleviating pressure on crowded ERs and offering more…
Acadia Pharmaceuticals announced that DAYBUE STIX (trofinetide) for oral solution, a dye- and preservative-free powder formulation of trofinetide, is now broadly…
Woburn, MA, April 06, 2026 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals, Inc. announced that ARYNTATM (lisdexamfetamine dimesylate) Oral Solution is now available in the…
MALVERN, Pa., April 07, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the–Company–), a medical technology company focused on designing, developing, and ...
Key Facts: SK Life Science, Inc. will present multiple posters at the American Academy of Neurology (AAN) Annual Meeting (April 18–22, 2026, Chicago, Illinois)…
Auto-brewery syndrome can wreak havoc on people’s lives and reputations. The post The mystifying syndrome that makes people spontaneously drunk appeared first on…
Newleos Therapeutics announced that the first participant has been dosed in the company's third Phase 1b study of NTX-1955, designed to evaluate its safety and…
This article reviews the evidence for magnesium, riboflavin, CoQ10, feverfew, vascular tone, and oxidative balance. It also highlights the growing field of nutritional…
A new review in The Lancet Psychiatry finds little evidence that marijuana reduces symptoms of anxiety, depression or PTSD while many users self‐medicate.
Cingulate Inc., a biopharmaceutical company developing ADHD treatments using its proprietary Precision Timed Release (PTR) drug delivery platform, reported fourth…
Seasoned leader brings more than 30 years of medical device experience, with a proven track record of growing revenue, earnings, and cash flow across multiple ...
By Sandee LaMotte, CNN (CNN) — Using medical or recreational marijuana to ease symptoms of numerous mental health conditions doesn’t work, according to two new analyses…
BY THE OPTIMIST DAILY EDITORIAL TEAM When anxiety starts creeping in, many people instinctively reach for music. A calming playlist, a pair of headphones, and a few…
Talk about your fears, normalise difficult emotions, get up and move: experts share their strategies for managing anxiety at different stages of lifeWe are living in an…
The Population Health Initiative awarded 13 $25,000 Tier 1 pilot grants in spring quarter 2024 to interdisciplinary University of Washington research teams to…